|
業務類別
|
-- |
|
業務概覽
|
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of itsrevenue from North America. |
| 公司地址
| Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900 |
| 電話號碼
| +45 45290000 |
| 傳真號碼
| +45 45290001 |
| 公司網頁
| https://www.bioporto.com |
| 員工數量
| 31 |
| Mr. Peter Morch Eriksen |
Director and Chief Executive Officer |
-- |
04/04/2024 |
|
|
| Mr. Peter Morch Eriksen |
Director and Chief Executive Officer |
04/04/2024 |
| Dr. Michael Singer, M.D.,PhD |
Independent Director |
04/04/2024 |
| Mr. John McDonough |
Chairman of the Board |
04/04/2024 |
| Dr. Ninfa M. Saunders |
Independent Director |
04/04/2024 |
| Mr. Donnie Mccoy Hardison, Jr |
Vice Chairman of the Board |
04/04/2024 |
|
|
|
|
